Literature DB >> 28283914

Transurethral Resection of Bladder Tumors: Improving Quality Through New Techniques and Technologies.

Daniel Zainfeld1, Siamak Daneshmand2.   

Abstract

PURPOSE OF REVIEW: Cystoscopy with transurethral resection of bladder tumors (TURBT) is essential in the diagnosis of bladder cancer as well as the management of non-muscle-invasive disease yet remains a comparatively imprecise procedure secondary to variability among patients, tumors, and surgeons alike. We will review evolving technologies and techniques used to enhance safety and efficacy of TURBT performance and education in the management of bladder cancer. RECENT
FINDINGS: Though a generally safe procedure, efficacy of TURBT in terms of complete tumor excision, appropriate pathologic diagnosis, and absence of complications can vary significantly with direct impact on patient outcomes. Application of new techniques including bipolar electrocautery and photodynamic enhancement continues to shape endoscopic management of bladder cancer and improve safety, tumor excision rates, and downstream outcomes. High-quality bladder tumor resection is essential for effective bladder cancer management. Technologies such as bipolar electrocautery and photodynamic visualization improve safety and tumor eradication. Improved education and surgical technique will further standardize high-level outcomes for patients undergoing TURBT.

Entities:  

Keywords:  Bipolar; Bladder cancer; Blue light; Monopolar; Transurethral resection

Mesh:

Year:  2017        PMID: 28283914     DOI: 10.1007/s11934-017-0680-0

Source DB:  PubMed          Journal:  Curr Urol Rep        ISSN: 1527-2737            Impact factor:   3.092


  53 in total

1.  The value of a second transurethral resection for T1 bladder cancer.

Authors:  Hartwig E Schwaibold; Sivaprakasam Sivalingam; Florian May; Rudolf Hartung
Journal:  BJU Int       Date:  2006-03-23       Impact factor: 5.588

2.  The effect of surgical duration of transurethral resection of bladder tumors on postoperative complications: An analysis of ACS NSQIP data.

Authors:  Richard S Matulewicz; Vidit Sharma; Barry B McGuire; Daniel T Oberlin; Kent T Perry; Robert B Nadler
Journal:  Urol Oncol       Date:  2015-06-10       Impact factor: 3.498

Review 3.  Hexyl aminolevulinate-guided fluorescence cystoscopy in the diagnosis and follow-up of patients with non-muscle-invasive bladder cancer: a critical review of the current literature.

Authors:  Michael Rink; Marko Babjuk; James W F Catto; Patrice Jichlinski; Shahrokh F Shariat; Arnulf Stenzl; Herbert Stepp; Dirk Zaak; J Alfred Witjes
Journal:  Eur Urol       Date:  2013-07-19       Impact factor: 20.096

4.  Hexaminolevulinate guided fluorescence cystoscopy reduces recurrence in patients with nonmuscle invasive bladder cancer.

Authors:  Arnulf Stenzl; Maximilian Burger; Yves Fradet; Lance A Mynderse; Mark S Soloway; J Alfred Witjes; Martin Kriegmair; Alexander Karl; Yu Shen; H Barton Grossman
Journal:  J Urol       Date:  2010-09-17       Impact factor: 7.450

5.  Thermal artifacts in bladder tumors following loop endoresection: electrovaporization v electrocauterization.

Authors:  Brunolf W Lagerveld; Rob A C Koot; Geert A H J Smits
Journal:  J Endourol       Date:  2004-08       Impact factor: 2.942

6.  A comparison of hexaminolevulinate fluorescence cystoscopy and white light cystoscopy for the detection of carcinoma in situ in patients with bladder cancer: a phase III, multicenter study.

Authors:  Yves Fradet; H Barton Grossman; Leonard Gomella; Seth Lerner; Michael Cookson; David Albala; Michael J Droller
Journal:  J Urol       Date:  2007-05-11       Impact factor: 7.450

7.  Bipolar transurethral resection in saline (TURis): outcome and complication rates after the first 1000 cases.

Authors:  Paolo Puppo; Franco Bertolotto; Carlo Introini; Francesco Germinale; Luca Timossi; Angelo Naselli
Journal:  J Endourol       Date:  2009-07       Impact factor: 2.942

8.  Analysis of the absence of the detrusor muscle in initial transurethral resected specimens and the presence of residual tumor tissue.

Authors:  Jiefu Huang; Jinggao Fu; Hailun Zhan; Keji Xie; Bolong Liu; Fei Yang; Yangbo Lu; Xiangfu Zhou
Journal:  Urol Int       Date:  2012-08-24       Impact factor: 2.089

9.  Presence of detrusor muscle in bladder tumor specimens--predictors and effect on outcome as a measure of resection quality.

Authors:  Ohad Shoshany; Roy Mano; David Margel; Jack Baniel; Ofer Yossepowitch
Journal:  Urol Oncol       Date:  2013-08-02       Impact factor: 3.498

10.  Comparison of the efficacy and feasibility of en bloc transurethral resection of bladder tumor versus conventional transurethral resection of bladder tumor: A meta-analysis.

Authors:  Yu-Peng Wu; Ting-Ting Lin; Shao-Hao Chen; Ning Xu; Yong Wei; Jin-Bei Huang; Xiong-Lin Sun; Qing-Shui Zheng; Xue-Yi Xue; Xiao-Dong Li
Journal:  Medicine (Baltimore)       Date:  2016-11       Impact factor: 1.889

View more
  7 in total

Review 1.  Enhanced Endoscopy in Bladder Cancer.

Authors:  Shane Pearce; Siamak Daneshmand
Journal:  Curr Urol Rep       Date:  2018-08-17       Impact factor: 3.092

Review 2.  Image-Guided Transurethral Resection of Bladder Tumors - Current Practice and Future Outlooks.

Authors:  Timothy C Chang; Gautier Marcq; Bernhard Kiss; Dharati R Trivedi; Kathleen E Mach; Joseph C Liao
Journal:  Bladder Cancer       Date:  2017-07-27

3.  Systematic review and meta-analysis on bipolar versus monopolar transurethral resection of bladder tumors.

Authors:  Wojciech Krajewski; Łukasz Nowak; Marco Moschini; Andrea Mari; Ettore Di Trapani; Evanguelos Xylinas; Andrzej Tukiendorf; Sławomir Poletajew; Romuald Zdrojowy
Journal:  Transl Androl Urol       Date:  2021-01

Review 4.  Transurethral resection of bladder tumour (TURBT).

Authors:  Lawrence H C Kim; Manish I Patel
Journal:  Transl Androl Urol       Date:  2020-12

5.  UNC5B mediates G2/M phase arrest of bladder cancer cells by binding to CDC14A and P53.

Authors:  Yexiang Huang; Yuyan Zhu; Zhe Zhang; Zhenhua Li; Chuize Kong
Journal:  Cancer Gene Ther       Date:  2020-05-06       Impact factor: 5.987

Review 6.  Current and innovative approaches in the treatment of non-muscle invasive bladder cancer: the role of transurethral resection of bladder tumor and organoids.

Authors:  Milena Taskovska; Mateja Erdani Kreft; Tomaz Smrkolj
Journal:  Radiol Oncol       Date:  2020-05-02       Impact factor: 2.991

7.  Virtual Reality and Simulation for Progressive Treatments in Urology.

Authors:  Alaric Hamacher; Taeg Keun Whangbo; Su Jin Kim; Kyung Jin Chung
Journal:  Int Neurourol J       Date:  2018-09-28       Impact factor: 2.835

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.